Effects on Soluble CD40L and Adipocytokines after Therapy and Withdrawal of Atorvastatin in Patients with Hypercholesterolemia
碩士 === 高雄醫學大學 === 醫學研究所碩士班 === 92 === Background: Enhanced soluble CD40 ligand (sCD40L) has been found participating in the prothrombotic status in patients with hypercholesterolemia and plaque instability in acute coronary syndrome. Two novel adipocytokines, including adiponectin and resistin, were...
Main Authors: | Chih-Sheng Chu, 朱志生 |
---|---|
Other Authors: | Wen-Ter Lai |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/19749180224987481108 |
Similar Items
-
Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents
by: Aynur Küçükçongar Yavaş, et al.
Published: (2017-03-01) -
Effects of Atorvastatin on Ventricular Late Potentials and Repolarization Dispersion in Patients with Hypercholesterolemia
by: Chih-Sheng Chu, et al.
Published: (2007-05-01) -
Immune Modulatory Effects of Hypercholesterolemia: Can Atorvastatin Convert the Detrimental Effect of Hypercholesterolemia on the Immune System?
by: Zeinab Emruzi, et al.
Published: (2019-10-01) -
Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
by: A D Marais, et al.
Published: (1997-10-01) -
Comparison of the effects of policosanol
and atorvastatin on postmenopausal women with type II hypercholesterolemia
by: Gladys Castaño, et al.
Published: (2008-01-01)